Cabaletta Bio, Inc. (CABA) KPIs and segments

CABANasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30

$1.28−0.05 (-3.76%)

Close on Nov 13, 2026Market cap $217.02MP/E –Yield –

KPIs & segments

Operating metrics and segments that drive Cabaletta Bio's business

Coming soon

This tab will track the numbers specific to Cabaletta Bio's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?